Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

A Diagnosis of Any Hematologic or Solid Malignancy clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

A Diagnosis of Any Hematologic or Solid Malignancy: 1 US clinical trial tracked, none currently recruiting.

A Diagnosis of Any Hematologic or Solid Malignancy is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Duke University, running 1 of these trials.

Enrollment posture brief

Registry condition a-diagnosis-of-any-hematologic-or-solid-malignancy

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%A Diagnosis of Any Hemat (th…0%
Open-enrollment share among volume-matched conditions near A Diagnosis of Any Hematologic or Solid Malignancy

A Diagnosis of Any Hematologic or Solid Malignancy has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for A Diagnosis of Any Hematologic or Solid Malignancy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. A Diagnosis of Any Hematologic or Solid Malignancy is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Duke University 1 trials

Named interventions

Most-linked intervention names on A Diagnosis of Any Hematologic or Solid Malignancy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Daily SMS text messaging Other
1 trials

US sites by state

Facility locations filed on A Diagnosis of Any Hematologic or Solid Malignancy trials. A trial with sites in several states counts in each.

North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this A Diagnosis of Any Hematologic or Solid Malignancy page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No A Diagnosis of Any Hematologic or Solid Malignancy trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Duke University sponsors the most A Diagnosis of Any Hematologic or Solid Malignancy trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This A Diagnosis of Any Hematologic or Solid Malignancy condition card totals 1 registered trials; most-linked intervention Daily SMS text messaging; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.